Boletín nanomedicina Enero Febrero 2011

1,803 views
1,723 views

Published on

Boletín mensual sobre Nanomediciona generado por VIGIALE, IALE Tecnología

Published in: Health & Medicine
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total views
1,803
On SlideShare
0
From Embeds
0
Number of Embeds
3
Actions
Shares
0
Downloads
19
Comments
0
Likes
1
Embeds 0
No embeds

No notes for slide

Boletín nanomedicina Enero Febrero 2011

  1. 1. Enero-Febrero 2011BoletínNanomedicina generado por VIGIALE, IALE Tecnología.
  2. 2. HIDDEN TEXT TO MARK THE BEGINNING OF THE TABLE OF CONTENTS INDICENOTICIAS 1. Bhasmas are nano-medicine of ancient times 2 2. Researchers Bring Plasmonic Nanofields Into Focus 2 3. Consiguen liberar ADN directamente en el núcleo celular mediante nanodiscos de proteínas 2 4. Nanosponges Harvest Rare Cancer Marker from Blood 3 5. Bold Medicine, Golden Innovation 3 6. Three Biotech IPOs Ahead This Week: AcelRx Pharma, Endocyte, Pacira Pharma 3 7. Cornell Dots that light up cancer cells go into clinical trials 4 8. Diagnostic chip may help hearts, cut costs 4 9. Plankton inspires creation of stealth armor for slow-release microscopic drug vehicles 4 10. The Welch Foundation Honors Rising Star For Stellar Work On Nanoparticles, Cell Membranes 5 11. Novel Cancer-Targeting Investigational Nanoparticle Receives FDA IND Approval For First-In-Huma... 5 12. Early tests find nanoshell therapy effective against brain cancer 5 13. Detecting Lethal Diseases With Rust and Sand 6 14. Physicists scale up invisibility cloaks using natural crystals 6 15. Crece en EEUU el mercado de productos médicos basados en nanotecnología 6 16. UB and Nigeria Partner to Further Nanomedicine Research 7 17. Nanobiotix and the ETPN launch the first Nanomedicine TV 7 18. Scientists Work on New System to Capture Ovarian Cancer Cells Using Magnetic Nanoparticles 7 19. Armor for nano drug release vehicles inspired by plankton 8 20. New nanoparticles make blood clots visible 8 21. UABs new 3-D nanoscaffold could revolutionize human tissue engineering. 8 22. DNA Backbone Assists Nanocrystal Formation 9 23. Scientists Model Tiny Rotors, Key to Future Nanomachines. 9 24. Early tests find nanoshell therapy effective against brain cancer 9PATENTES 25. Patentes publicadas este mes 10 26. Origen de los principales actores del mes 10 27. Principales entidades que patentaron este mes 11 28. Principales inventores que patentaron este mes 11 29. Principales temas tratados en las patentes del mes 12 30. US20110014124A1 Targeted Atherosclerosis treatment 12 31. US20110021894A1: Glucose sensor employing semiconductor nanoelectronic device 13 32. US20110014131A1: Nanomolding micron and nano scale features 13
  3. 3. INDICE 33. US20110014118A1: Nanotherapeutic colloidal metal compositions and methods 13 34. US20110020243A1: Methods and compositions for imaging cancer cells 14 35. US20110020788A1: NMR device for detection of analytes 14 36. US20110020434A1: Nanoparticle arsenic-platinum compositions 15 37. US20110014264A1: Medical devices having nanostructured regions for controlled tissue biocompati... 15 38. US7871990 Nanoparticles for protein drug delivery 15 39. US7871591 Methods for growing long carbon single-walled nanotubes 16 40. WO2007070572 Probe for nucleic acid sequencing and methods of use. 16 41. CN11317840A: Nano-composition, preparing method and application thereof 17 42. WO2010151173A1: Nano-dispersed composition containing COenzima Q10 and method for producing 17sam... 43. CZ20090496A3: Process for producing nanofiber-based nanopellets 17EVENTOS, CURSOS YSEMINARIOS 44. 4th European Conference for Clinical Nanomedicine 2011 (CLINAM 2011) 18 45. Conference Innovation in Healthcare: from Research to Market 18 46. 2nd Australian & New Zealand Micro and Nanofluidics Symposium. 18 47. Tercer Encuentro sobre Nanociencia y Nanotecnología (NANOUCO III) 19 48. Nanobiomedica Conference 19 49. Nanotech 2011 Exxhibition & Conference 20 50. First Annual Nanodermatology Society Meeting 20 51. ImagineNano Conference 20 52. 3rd NanoImpactNet Conference 21 53. Nanomedicine Commercialization Workshop 21 54. Jornadas: Clinical Applications of Nanotechnologies in the Field of Cancer 21 55. Jornada "Nanomedicina en España: Presente y Futuro" 22ARTÍCULOS-CIENTÍFICOS 56. Principales investigadores que publicaron este mes 22 57. Principales entidades con publicaciones este mes 23 58. Principales temas tratados en los artículos científicos del mes 23 59. Three-dimensional atomic imaging of crystalline nanoparticles 24 60. Synthesis, functionalization and bioimaging applications of highly fluorescent carbon nanoparti... 24 61. Hard-tip, soft-spring lithography 24 62. Combined Small Interfering RNA Therapy and In Vivo Magnetic Resonance Imaging in Islet 25
  4. 4. INDICETranspla... 63. Enhanced Lysozyme Imprinting Over Nanoparticles Functionalized with Carboxyl Groups for 25Noncova... 64. Bioengineering Single Crystal Growth. 26 65. Unfolding and translocation pathway of substrate protein controlled by structure in repetitive ... 26 66. Modulation of biological processes in the nucleus by delivery of DNA oligonucleotides conjugate... 27 67. Multifunctional gadolinium-based dendritic macromolecules as liver targeting imaging probes 27 68. Synthesis, characterization and cytotoxicity studies of chitosan-coated tea polyphenols nanopar... 28 69. In situ green synthesis of biocompatible ginseng capped gold nanoparticles with remarkable stab... 28 70. Enhancement of cell recognition in vitro by dual-ligand cancer targeting gold nanoparticles 28 71. Hemocompatible pullulan-polyethyleneimine conjugates for liver cell gene delivery: In vitro eva... 29 72. Proteins of the Innate Immune System Crystallize on Carbon Nanotubes but Are Not Activated 29 73. Liposomal architecture boosts biocompatibility of nanohybrid cerasomes 30 74. Nanosilver induces minimal lung toxicity or inflammation in a subacute murine inhalation model 30 75. A living cell quartz crystal microbalance biosensor for continuous monitoring of cytotoxic res... 30 76. Inflammatory and cytotoxic responses of an alveolar-capillary coculture model to silica nanopar... 31 77. Carbosilane dendrimers NN8 and NN16 form a stable complex with siGAG1 31REPORTES 78. Nanomedicina en España 06-10 31 79. Podcast: The Implications for Health, Safety and the Environment of the Nanotech Revolution 32 80. Action Plan Nanotechnology 2015 32 81. HTSM vision document: High Tech Systems and Material 32 82. 2010 Nanotechnology Research Review 33 83. Nanotechnology Market Forecast to 2013 33 84. Nanotechnologies in the 21st century 33 85. Nanotechnology Research Directions for Societal Needs in 2020. Retrospective and Outlook 34NORMATIVAS 86. AENOR - Normativas de Nanotecnología 34
  5. 5. Nanomedicina NOTICIAS Bhasmas are nano-medicine of ancient times Publicada el 02/04/2011. While the concept of reduction in particle size of metals is prevailing since Charak Samhita, the oldest classical text in ayurveda, the recent studies at the department of Rasa Shashtra, Faculty of Ayurveda, Banaras Hindu University, has claimed the herbo-mineral formulations of ayurveda constituting bhasma to be equivalent and in tune with nanotechnology witnessing production of nanoparticles in contemporary era. ver más... Researchers Bring Plasmonic Nanofields Into Focus Publicada en Institute of Nanotechnology News, 02/04/2011. In typical plasmonic devices, electromagnetic waves crowd into tiny metal structures, concentrating energy into nanoscale dimensions. Due to coupling of electronics and photonics in these metal nanostructures, plasmonic devices could be harnessed for high-speed data transmission or ultrafast detector arrays. ver más... Consiguen liberar ADN directamente en el núcleo celular mediante nanodiscos de proteínas Publicada el 02/03/2011. Investigadores de la Universitat Autónoma de Barcelona han conseguido encapsular material genético y liberarlo directamente dentro del núcleo de las células, para llevar a cabo terapia génica, mediante partículas con forma de disco del tamaño de sólo unos nanómetros. Los nanodiscos, tal y como los han bautizado los investigadores, atraviesan rápidamente el interior de la célula y se concentran en el núcleo, de forma que incrementarían la eficiencia del proceso de transferencia genética. ver más...Enero-Febrero 2011 Página 2
  6. 6. Nanomedicina Nanosponges Harvest Rare Cancer Marker from Blood Publicada el 02/03/2011. An international research team from the United States and Italy has shown that it can use a new type of nanoparticle to selectively trap specific families of proteins from blood and protect them from degradation by enzymes in blood. ver más... Bold Medicine, Golden Innovation Publicada el 02/03/2011. The gold-coated liposomes being developed at the UA could offer a new way to target delivery of drugs to cancerous regions of the body, non-invasively trigger the drugs release using infrared light, and provide a way for the body to naturally eliminate the toxic byproducts. ver más... Three Biotech IPOs Ahead This Week: AcelRx Pharma, Endocyte, Pacira Pharma Publicada el 02/03/2011. AcelRx Pharmas - developing ARX-01, the Sufentanil NanoTab PCA System, for the management of acute post- operative pain in adult patients during hospitalization Endocytes - Biopharma developing targeted therapies for the treatment of cancer and inflammatory diseases. Pacira Pharmas - Has filed a New Drug Application, or NDA, for the lead product candidate, EXPAREL, a long-acting bupivacaine (anesthetic/analgesic) product for postsurgical pain management. ver más...Enero-Febrero 2011 Página 3
  7. 7. Nanomedicina Cornell Dots that light up cancer cells go into clinical trials Publicada el 02/03/2011. "Cornell Dots" brightly glowing nanoparticles may soon be used to light up cancer cells to aid in diagnosing and treating cancer. The U.S. Food and Drug Administration (FDA) has approved the first clinical trial in humans of the new technology. It is the first time the FDA has approved using an inorganic material in the same fashion as a drug in humans. ver más... Diagnostic chip may help hearts, cut costs Publicada el 02/03/2011. During National Heart Health Month, Rice Professor John McDevitt will discuss the potential of this technology to detect cardiac disease early at the annual meeting of the American Association for the Advancement of Science (AAAS) in Washington, D.C., Feb. 17-21. Cardiac disease is the focus of one of six ongoing major clinical trials of Rices programmable bio-nano-chips (PBNCs). ver más... Plankton inspires creation of stealth armor for slow-release microscopic drug vehicles Publicada el 02/03/2011. The ability of some forms of plankton and bacteria to build an extra natural layer of nanoparticle-like armour has inspired chemists at the University of Warwick to devise a startlingly simple way to give drug bearing polymer vesicles (microscopic polymer based sacs of liquid) their own armoured protection. ver más...Enero-Febrero 2011 Página 4
  8. 8. Nanomedicina The Welch Foundation Honors Rising Star For Stellar Work On Nanoparticles, Cell Membranes Publicada el 02/03/2011. The Welch Foundation has awarded its prestigious Hackerman Award to Rice University scientist Jason Hafner 96, who was named this years "rising star" for his innovative chemical research. Hafners discoveries include a new type of nanostructure called gold nanostars, which are proving useful for sensing, imaging and medicine, and the first method for measuring large electrical fields inside cell membranes. ver más... Novel Cancer-Targeting Investigational Nanoparticle Receives FDA IND Approval For First-In-Human Trial Publicada el 02/03/2011. Researchers at Memorial Sloan-Kettering Cancer Centers Nanotechnology Center, along with collaborators at Cornell University and Hybrid Silica Technologies, have received approval for their first Investigational New Drug Application (IND) from the US Food and Drug Administration (FDA) for an ultrasmall silica inorganic nanoparticle platform for targeted molecular imaging of cancer, which may be useful for cancer treatment in the future. ver más... Early tests find nanoshell therapy effective against brain cancer Publicada el 02/03/2011. Rice University bioengineers and physician-scientists at Baylor College of Medicine and Texas Childrens Hospital have successfully destroyed tumors of human brain cancer cells in the first animal tests of a minimally invasive treatment that zaps glioma tumors with heat. The tests involved nanoshells, light-activated nanoparticles that are designed to destroy tumors with heat and avoid the unwanted side effects of drug and radiation therapies. ver más...Enero-Febrero 2011 Página 5
  9. 9. Nanomedicina Detecting Lethal Diseases With Rust and Sand Publicada el 02/03/2011. The next big thing in medical diagnostics could be minutes particles of rust, iron oxide, coated with the material from which sand is formed, silicon dioxide. These magnetic nanoparticles, a mere 29 to 230 nanometers across, can be used to trap antibodies to the virus that causes cervical cancer and to the bacteria that causes potentially lethal diarrhea. ver más... Physicists scale up invisibility cloaks using natural crystals Publicada el 02/03/2011. Physicists from the University of Birmingham, with colleagues at Imperial College, London, and Technical University of Denmark, have demonstrated an invisibility cloak that can hide a three-dimensional object, centimetres in dimension, large enough for the cloaking area to be visible to the human eye, according to research published today in the journal Nature Communications. ver más... Crece en EEUU el mercado de productos médicos basados en nanotecnología Publicada el 02/03/2011. El mercado de nanomedicinas experimentará un fuerte crecimiento a largo plazo, alcanzando los 59.000 millones de dólares (43.840 millones de euros) en 2014 y hasta 118.000 millones (87.700 millones de euros) para el ejercicio de 2019, debido a la necesidad de terapias nuevas o mejoradas para muchas enfermedades. Las terapias contra el cáncer avanzado, enfermedades autoinmunes, trastornos neurológicos e infecciones virales darán lugar a la introducción de nuevos productos y presentarán las mayores oportunidades de crecimiento. ver más...Enero-Febrero 2011 Página 6
  10. 10. Nanomedicina UB and Nigeria Partner to Further Nanomedicine Research Publicada el 02/03/2011. The Institute for Lasers, Photonics, and Biophotonics (ILPB) at the University at Buffalo signed a Memorandum of Understanding (MOU) with the National Universities Commission (NUC) of Abuja, Nigeria. The MOU called for the development of an international joint research center for nanomedicine at Nigerian universities. ver más... Nanobiotix and the ETPN launch the first Nanomedicine TV Publicada el 02/03/2011. Nanomed TV www.dailymotion.com/nanomedTV foresees to become the main hub for Nanomedicine thanks to its initiators, two major European players in nanomedicine: the European Technology Platform on Nanomedicine (ETPN) and Nanobiotix. Nanomed TV will make information accessible, aiming at answering what people need and wish to know about Nanomedicine. ver más... Scientists Work on New System to Capture Ovarian Cancer Cells Using Magnetic Nanoparticles Publicada el 02/03/2011. A paper published in the January issue of the journal Nanomedicine could provide the foundation for a new ovarian cancer treatment option -- one that would use an outside-the-body filtration device to remove a large portion of the free-floating cancer cells that often create secondary tumors. ver más...Enero-Febrero 2011 Página 7
  11. 11. Nanomedicina Armor for nano drug release vehicles inspired by plankton Publicada el 02/03/2011. One of the promising areas in the field of nanomedicine is the development of vesicles microscopic polymer sacs, designed to deliver a payload of medication to specific sites in the body. Unfortunately, the bodys immune system often sees these vesicles as intruders, sending antibodies to thwart them in their mission. Now, drawing inspiration from plankton and bacteria, chemists from the University of Warwick are developing armor coatings that should help vesicles to withstand or avoid those attacks. ver más... New nanoparticles make blood clots visible Publicada en Nanotechweb.org News, 02/02/2011. For almost two decades, cardiologists have searched for ways to see dangerous blood clots before they cause heart attacks. Now, researchers at Washington University School of Medicine in St. Louis report that they have designed nanoparticles that find clots and make them visible to a new kind of X-ray technology. ver más... UABs new 3-D nanoscaffold could revolutionize human tissue engineering. Publicada en Nanotechwire.com - Bio/Medicine, 02/02/2011. Researchers from the University of Alabama at Birminghams School of Engineering have created a three- dimensional electrospun scaffold on the nano scale that more effectively and efficiently facilitates cell and tissue growth in the laboratory. ver más...Enero-Febrero 2011 Página 8
  12. 12. Nanomedicina DNA Backbone Assists Nanocrystal Formation Publicada en Nanotechnology Now, 02/02/2011. Recently, researchers from University of Rochester Medical Center, Scripps Research Institute, and Massachusetts Institute of Technology published a paper in Nature Materials describing the first time a lattice was made using a combination of nano-sized metal particles (gold in this case) and organic materials (viral particles). The gold and viral phage capsid particles repel each other, but by stragetically placing them on DNA strands that attract one another, a rigid crystal structure can be created, with potential uses in optical computing and telecommunications. ver más... Scientists Model Tiny Rotors, Key to Future Nanomachines. Publicada en Nanomedicine Research - News, 02/02/2011. Kolomeisky and Rice graduate student Alexey Akimov have taken a large step toward defining the behavior of these molecular whirligigs with a new paper in the American Chemical Societys Journal of Physical Chemistry C. Through molecular dynamics simulations, they defined the ground rules for the rotor motion of molecules attached to a gold surface. ver más... Early tests find nanoshell therapy effective against brain cancer Publicada en Nanotechweb.org News, 02/01/2011. Rice University bioengineers and physician-scientists at Baylor College of Medicine and Texas Childrens Hospital have successfully destroyed tumors of human brain cancer cells in the first animal tests of a minimally invasive treatment that zaps glioma tumors with heat. The tests involved nanoshells, light-activated nanoparticles that are designed to destroy tumors with heat and avoid the unwanted side effects of drug and radiation therapies. ver más...Enero-Febrero 2011 Página 9
  13. 13. Nanomedicina PATENTES Patentes publicadas este mes Publicada el 02/04/2011. Fuente: Espacenet, USPTO, OMPI, JPO, DEPATISnet, INPADOC Origen de los principales actores del mes Publicada el 02/04/2011. Fuente: Espacenet, UPSTOEnero-Febrero 2011 Página 10
  14. 14. Nanomedicina Principales entidades que patentaron este mes Publicada el 02/04/2011. Fuente: Espacenet, UPSTO Principales inventores que patentaron este mes Publicada el 02/04/2011. Fuente: Espacent, UPSTOEnero-Febrero 2011 Página 11
  15. 15. Nanomedicina Principales temas tratados en las patentes del mes Publicada el 02/04/2011. Fuente: Espacenet, USPTO US20110014124A1 Targeted Atherosclerosis treatment Publicada el 02/03/2011. Inventores: Lanza, Gregory M.; Wickline, Samuel A Titulares: Lanza, Gregory M.; Wickline, Samuel A Resumen: This invention relates generally to methods for ameliorating at least one symptom or aspect of atherosclerosis. A method for inhibiting atherosclerotic plaques in a subject which method comprises administering to a subject diagnosed with atherosclerosis, a composition comprising a nanoparticulate carrier contained in an emulsion and an v3 targeting ligand and an anti-angiogenic agent, wherein the targeting ligand and anti-angiogenic agent are coupled through colocalization in said nanoparticles. ver más...Enero-Febrero 2011 Página 12
  16. 16. Nanomedicina US20110021894A1: Glucose sensor employing semiconductor nanoelectronic device Publicada el 02/03/2011. Inventores: Mohanty, Pritiraj; Erramilli, Shyamsunder; Wang, Xihua; Chen, Yu; Titular: Trustees of Boston University (EE.UU.) Resumen: A glucose sensor employs a programmable glucose sensor array of a relatively large number of nanoelectronic devices (e.g. semiconductor field-effect devices) having control surfaces functionalized with a glucose-reactive substance and generating sensing signals indicative of sensed glucose level of a bodily fluid. The devices are divided into sub-sets sequentially enabled over successive intervals to achieve overall sensor lifetime many times longer than the lifetime of any single device in operation. ver más... US20110014131A1: Nanomolding micron and nano scale features Publicada el 02/03/2011. Inventores: Disawal, Sandeep; Rosner, Bjoem; Janosky, Robert J.; Titular: NanoInk, Inc (EE.UU.) Resumen: Small scale and nanoscopic identification features can be fabricated for pharmaceutical capsules. A composition comprising a capsule component, wherein the capsule component comprises a gelled pharmaceutical capsule material and at least one surface, wherein the at least one surface comprises at least one integral feature with a lateral dimension smaller than about 100 microns, or less than one micron. Methods of making the same are described by gelation with heating or cooling. The compositions and methods can be used for anti-counterfeiting. ver más... US20110014118A1: Nanotherapeutic colloidal metal compositions and methods Publicada el 02/03/2011. Inventores: Tamarkin, Lawrence; Pacciotti, Giulio F.; Huhta, Marja S. Titulares: Tamarkin, Lawrence; Pacciotti, Giulio F.; Huhta, Marja S. (EE.UU.) Resumen: The present invention comprises compositions and methods for delivery systems of agents, including therapeutic compounds, pharmaceutical agents, drugs, detection agents, nucleic acid sequences and biological factors. In general, the nanotherapeutic compositions of the present invention comprise a platform comprising a colloidal metal, a targeting ligand such a tumor necrosis factor, a stealth agent such as polyethylene glycol, and one or more diagnostic or therapeutic agents for delivery. The invention also comprises methods and compositions for making such nanotherapeutic compositions and for theEnero-Febrero 2011 Página 13
  17. 17. Nanomedicina treatment of cancer. ver más... US20110020243A1: Methods and compositions for imaging cancer cells Publicada el 02/03/2011. Inventor: Aydogan, Bulent Titular: Aydogan, Bulent Resumen: Disclosed are compositions comprising nanoparticles and uses thereof. Such nanoparticles include gold nanoparticles conjugated to glucose or a glucose derivative, which are useful as contrast agents in imaging methods such as computed tomography (CT). Nanoparticles disclosed herein are useful in imaging various cells, tissues, and organs, and are particularly useful in imaging tumors and tumor cells in vitro and in vivo. ver más... US20110020788A1: NMR device for detection of analytes Publicada el 02/03/2011. Inventor: Lee, W. David Titular: T2 Biosystems, Inc (EE.UU.) Resumen: This invention relates generally to detection devices having one or more small wells each surrounded by, or in close proximity to, an NMR micro coil, each well containing a liquid sample with magnetic nanoparticles that self- assemble or disperse in the presence of a target analyte, thereby altering the measured NMR properties of the liquid sample. The device may be used, for example, as a portable unit for point of care diagnosis and/or field use, or the device may be implanted for continuous or intermittent monitoring of one or more biological species of interest in a patient. ver más...Enero-Febrero 2011 Página 14
  18. 18. Nanomedicina US20110020434A1: Nanoparticle arsenic-platinum compositions Publicada el 02/03/2011. Inventores: OHalloran, Thomas V.; Chen, Haimei; Mazar, Andrew Titulares: OHalloran, Thomas V.; Chen, Haimei; Mazar, Andrew (EE.UU.) Resumen: The present invention relates to nanoparticle encapsulated arsenic and platinum compositions and methods of use thereof. In particular, the present invention provides co-encapsulation of active forms of arsenic and platinum drugs into liposomes, and methods of using such compositions for the diagnosis and treatment of cancer. ver más... US20110014264A1: Medical devices having nanostructured regions for controlled tissue biocompatibility and drug delivery Publicada el 02/03/2011. Inventores: Helmus, Michael N.; Xu, Yixin; Ranade, Shrirang V.; Titulares: Boston Scientific Scimed, Inc. Resumen: According to certain aspects of the invention, implantable or insertable medical devices are provided that contain one or more nanoporous regions, which may further comprise interconnected nanopores. Other aspects of the invention are directed to implantable or insertable medical devices that contain one or more nanostructured regions, which are formed by a variety of methods. Still other aspects of the invention are directed to implantable or insertable medical devices having nanotextured surface regions, in which cell-adhesion-promoting biomolecules (e.g., glycosaminoglycans, proteoglycans, cell adhesion peptides, and adhesive proteins) are provided on, within or beneath the nanotextured surface regions. ver más... US7871990 Nanoparticles for protein drug delivery Publicada el 02/02/2011. Inventores: Sung Hsing-Wen, Liang Hsiang-Fa, Tu Hosheng Assignee: GP Medical, Inc. (EE.UU.) Resumen: The invention discloses the nanoparticles composed of chitosan, poly-glutamic acid, and at least one protein drug or bioactive agent characterized with a positive surface charge and their enhanced permeability for paracellular protein drug and bioactive agent delivery. ver más...Enero-Febrero 2011 Página 15
  19. 19. Nanomedicina US7871591 Methods for growing long carbon single-walled nanotubes Publicada el 02/02/2011. Inventores: Harutyunyan Avetik, Mora Elena, Tokune Toshio Titular: Honda Motor Co.,Ltd. (Japón) Resumen: Methods and processes for synthesizing single-wall carbon nanotubes are provided. A carbon precursor gas is contacted with metal catalysts deposited on a support material. The metal catalysts are preferably nanoparticles having diameters less than about 3 nm. The reaction temperature is selected such that it is near the eutectic point of the mixture of metal catalyst particles and carbon. Further, the rate at which hydrocarbons are fed into the reactor is equivalent to the rate of formation of carbon SWNTs for given synthesis temperature. The methods produce carbon single-walled nanotubes having longer lengths. ver más... WO2007070572 Probe for nucleic acid sequencing and methods of use. Publicada en Scirus - Patentes sobre Nanomedicina, 02/02/2011. Inventores: Schneider Thomas D., Lyakhov Ilya G., Needle Danielle Titular: Department of Health and Human Services (EE.UU.) Resumen: A nanoprobe for sequencing of nucleic acid molecules is provided, as well as methods for using the nanoprobe. In particular examples, the probe includes a polymerizing agent and one or more molecular linkers that carry a chemical moiety capable of reversibly binding to the template strand of a nucleic acid molecule, without being detached from the linker, by specifically binding with a complementary nucleotide in the target nucleic acid molecule. The reversible binding of the chemical moiety on the linker with a complementary nucleotide in the target nucleic acid molecule is indicated by emission of a characteristic signal that indicates pairing of the chemical moiety on the linker with its complementary nucleotide. An example of such... ver más...Enero-Febrero 2011 Página 16
  20. 20. Nanomedicina CN11317840A: Nano-composition, preparing method and application thereof Publicada el 02/02/2011. Inventores: Yawei Zhou Titular: Yawei Zhou Resumen: Nanocomposite for preparing medicine for treating hepatitis, comprises silibinin and carrier material wheat gliadin having predetermined grain size. URL: no disponible. ver más... WO2010151173A1: Nano-dispersed composition containing COenzima Q10 and method for producing same Publicada el 02/02/2011. Inventores:Pozharitskaya Olga Nikolaevna; Karlina Marina Valerievna; Shikov Alexandr Nikolaevich; Makarov Valeriy Gennadievich (Rusia) Titular:Patsiya Merabi Georgievich; Pozharitskaya Olga Nikolaevna; Karlina Marina Valerievna; Shikov Alexandr Nikolaevich; Makarov Valeriy Gennadievich (Rusia) Resumen: Coenzyme Q10 nanocomposition useful in the food, pharmaceutical and cosmetic industries comprises polyethylene glycol and coenzyme Q10 ver más... CZ20090496A3: Process for producing nanofiber-based nanopellets Publicada el 02/02/2011. Inventores: Amler EV EN y otros. Titulares: Student Science, Nanopharma, Technicka Univerzita y Liberci, Astav EX Mediciny AV CR VVI, Univerzita Karlova V Praze 2 Lakarska Fakulta (República Checa). Resumen: No disponible ver más...Enero-Febrero 2011 Página 17
  21. 21. Nanomedicina EVENTOS, CURSOS Y SEMINARIOS 4th European Conference for Clinical Nanomedicine 2011 (CLINAM 2011) Publicada el 02/03/2011. CLINAM 2011 will highlight the joint European way of working together for a future healthcare-based on a cooperative approach between leading edge technology and science, research, clinical experience, policy, politics, regulations and industry stakeholders. Fecha: 23-25 Mayo 2011 Lugar: Basel, Suiza ver más... Conference Innovation in Healthcare: from Research to Market Publicada el 02/02/2011. European Commissions DGs Research and Innovation, Enterprise and Industry and Health and Consumers are jointly organising the Conference Innovation in Healthcare: from Research to Market. The objective of the 2011 conference is to produce an analysis of the strengths, weaknesses, opportunities and threats (SWOT) for innovation in healthcare and make specific recommendations that will be addressed to policy-makers and stakeholders. Fecha: 30-31, Marzo 2011 Lugar: Brussels ver más... 2nd Australian & New Zealand Micro and Nanofluidics Symposium. Publicada en Nanotechnology Network - Events, 02/02/2011. This is the only event of its kind in Australia which brings together the multidisciplinary researchers in micro/nano fluidics. The inaugural event had speakers from Mechanical and Chemical Engineering, Physics, Chemistry and Biology and we expect this event to be at least that broad, and thus to help foster interdisciplinary collaboration. It will be held in the newly finished design studio in Mechanical Engineering which is a multifunctional space with excellent audiovisual facilities. We plan to have one invited speaker, Prof. Steven Wereley from Purdue; one of the founders of diagnostic microfluidics and the author of the definitive book in the field. Fecha: 28 - 29 abril, 2011 Lugar: University of New South WalesEnero-Febrero 2011 Página 18
  22. 22. Nanomedicina ver más... Tercer Encuentro sobre Nanociencia y Nanotecnología (NANOUCO III) Publicada en NanoSpain - Eventos, 02/02/2011. La tercera edición del Encuentro sobre Nanociencia y Nanotecnología (NANOUCO III), que se celebrará en la Universidad de Córdoba los días 10 y 11 de febrero de 2011, pretende ser un punto de encuentro donde se fomente el intercambio de ideas y la cooperación entre investigadores y tecnólogos de organismos públicos y empresas de ámbito andaluz. Fecha: 10-11 Febrero, 2011 Lugar: Córdoba, España ver más... Nanobiomedica Conference Publicada en NanoConferences.com, 02/02/2011. A conference focusing on educating and promoting the benefits of nanobiotechnology, the emerging paradigm of medicine, for the Mexican health industry and showcasing innovative solutions, research and technology. NanoBioMedica is the only nanobiotech conference in Mexico providing strategic information for education, infrastructure development and capital investment. Whether operating in the private or public spheres, learn more about nanobiotechnology and the major role it will play in the decades to come. With a special daylong workshop provided by the Institute of Nanotechnology and a line-up of keynote speakers and workshops highlighting success stories and research from around the globe and in Mexico, NanoBioMedica is the perfect platform to learn the latest nanobiotecnology trends in order to revitalize and capitalize on the strengths of the Mexican private and... ver más...Enero-Febrero 2011 Página 19
  23. 23. Nanomedicina Nanotech 2011 Exxhibition & Conference Publicada en Fundación Phanton - Events, 02/02/2011. Again this year, we will be covering the entire nano marketplace and creating a variety of business opportunities at Tokyo Big Sight by concurrently holding; nano tech 2011. Fecha: 16-18 Febrero Lugar: Tokyo, Japón ver más... First Annual Nanodermatology Society Meeting Publicada en AzoNanotechnology-Eventos, 02/02/2011. We have lined up an outstanding faculty of nanotechnology experts to speak on clinically important topics on new and emerging technologies including: ..Nanodrug delivery for cutaneous infection ..Nanotechnology in cosmecueticals ..Nanodrug delivery for acne/rosacea ..Nanoparticles for the management of cutaneous malignancy ..Nanotechnology and the immune system ..Sunscreens and nanotechnology ..Nanotechnology and the treatment of genetic diseases ..Nanotoxicology ..Intellectual property in nanotechnology Fecha: 4 Febrero, 2011 Lugar: Hilton New Orleans Riverside, New Orleans ver más... ImagineNano Conference Publicada el 02/02/2011. ImagineNano will comprise in 15.000 m2, 5 conferences in parallel, a huge exhibition carried out with the latest nanotrends for the future and a social component where everyone can meet and greet Nanotechnology side by side. Fecha: 11-14 Abril 2011 Lugar: Bilbao, España ver más...Enero-Febrero 2011 Página 20
  24. 24. Nanomedicina 3rd NanoImpactNet Conference Publicada el 02/01/2011. NanoImpactNet is a multidisciplinary European network on the health and environmental impact of nanomaterials. NanoImpactNet will create a scientific basis to ensure the safe and responsible development of engineered nanoparticles and nanotechnology-based materials and products, and will support the definition of regulatory measures and implementation of legislation in Europe. Fecha: 14 - 17 de Febrero, 2011. Lugar: Lausanne, Switzerland ver más... Nanomedicine Commercialization Workshop Publicada el 02/01/2011. The topic of the workshop will be "Actionable Strategies for Company Building & Moving to Market". This workshop is an add-on to the established North Carolina Nanotechnology Commercialization Conference, which is hosted by the North Carolina Department of Commerce, in partnership with the Charlotte Research Institute, the Small Business and Technology Development Center, and COIN. Fecha: 29 de Marzo, 2011 Lugar: Barnhardt Center, UNC-Charlotte. ver más... Jornadas: Clinical Applications of Nanotechnologies in the Field of Cancer Publicada el 01/28/2011. Tres instituciones líderes en el área de aplicación de la nanotecnología para el tratamiento y diagnóstico del cáncer (Cancéropôle Lyon Auvergne Rhône-Alpes, Cancéropôle Grand Sud-Ouest, y el Instituto de Bioingeniería de Cataluña / BIOPOL L´H) co-organizan las jornadas Clinical Applications of Nanotechnologies in the Field of Cancer. Fecha: 28 y 29 de Enero, 2011 Lugar: Montpellier, Francia ver más...Enero-Febrero 2011 Página 21
  25. 25. Nanomedicina Jornada "Nanomedicina en España: Presente y Futuro" Publicada el 01/28/2011. La Plataforma Española de Nanomedicina organiza, la jornada Nanomedicina en España: Presente y Futuro. Dicha jornada tiene como referente el Roadmap 2020, publicado a finales de 2009 por la European Platform on Nanomedicine (ETPN), donde se proponían rutas de desarrollo concretas para hacer llegar la Nanomedicina a la clínica, asegurando el liderazgo europeo en este sector emergente. Fecha: 01 Febrero 2011 Lucgar: Sede CDTI, C/Cid 4, 28001 Madrid ver más... ARTÍCULOS-CIENTÍFICOS Principales investigadores que publicaron este mes Publicada el 02/04/2011. Fuente: ScopusEnero-Febrero 2011 Página 22
  26. 26. Nanomedicina Principales entidades con publicaciones este mes Publicada el 02/04/2011. Fuente: Scopus Principales temas tratados en los artículos científicos del mes Publicada el 02/04/2011. Fuente: ScopusEnero-Febrero 2011 Página 23
  27. 27. Nanomedicina Three-dimensional atomic imaging of crystalline nanoparticles Publicada en Nanomedicine Research Publicaciones, 02/03/2011. Autores: Sandra Van Aert, Kees J. Batenburg, Marta D. Rossell, Rolf Erni, Gustaaf Van Tendeloo Resumen: Here we report the 3D reconstruction of a complex crystalline nanoparticle at atomic resolution. To achieve this, we combined aberration-corrected scanning transmission electron microscopy, statistical parameter estimation theory and discrete tomography. Unlike conventional electron tomography, only two images of the targeta silver nanoparticle embedded in an aluminium matrixare sufficient for the reconstruction when combined with available knowledge about the particles crystallographic structure. Additional projections confirm the reliability of the result. The results we present help close the gap between the atomic resolution achievable in two-dimensional electron micrographs and the coarser resolution that has hitherto been obtained by conventional electron tomography. ver más... Synthesis, functionalization and bioimaging applications of highly fluorescent carbon nanoparticles Publicada en RSC - Nanoscale latest articles, 02/02/2011. Autores: Sourov Chandra, Pradip Das, Sourav Bag, Dipranjan Laha, Panchanan Pramanik Resumen: A novel method for synthesizing fluorescent CNPs and their functionalization for enhancement of their PL property with minimum cytotoxicity are reported. ver más... Hard-tip, soft-spring lithography Publicada el 02/02/2011. Autores: W Shim, AB Braunschweig, X Liao, J Chai, JK Lim, G Zheng, CA Mirkin Resumen: Nanofabrication strategies are becoming increasingly expensive and equipment-intensive, and consequently less accessible to researchers. As an alternative, scanning probe lithography has become a popular means of preparing nanoscale structures, in part owing to its relatively low cost and high resolution, and a registration accuracy that exceeds most existing technologies. However, increasing the throughput of cantilever-based scanning probe systems while maintaining their resolution and registration advantages has from the outset been a significant challenge. Even with impressive recent advances in cantilever array design, such arrays tend to be highly specialized for a given application, expensive, and often difficult to implement. It is therefore difficult to imagine commercially... ver más...Enero-Febrero 2011 Página 24
  28. 28. Nanomedicina Combined Small Interfering RNA Therapy and In Vivo Magnetic Resonance Imaging in Islet Transplantation Publicada el 02/02/2011. Autores: P Wang, MV Yigit, Z Medarova, L Wei, G Dai, C Schuetz, A Moore Resumen: Recent advances in human islet transplantation are hampered by significant graft loss shortly after transplantation and inability to follow islet fate directly. Both issues were addressed by utilizing a dual-purpose therapy/imaging small interfering RNA (siRNA)-nanoparticle probe targeting apoptotic-related gene caspase-3. We expect that treatment with the probe would result in significantly better survival of transplanted islets, which could be monitored by in vivo magnetic resonance imaging (MRI). RESEARCH DESIGN AND METHODS We synthesized a probe consisting of therapeutic (siRNA to human caspase-3) and imaging (magnetic iron oxide nanoparticles, MN) moieties. In vitro testing of the probe included serum starvation of the islets followed by treatment with the probe. Caspase-3 gene silencing... ver más... Enhanced Lysozyme Imprinting Over Nanoparticles Functionalized with Carboxyl Groups for Noncovalent Template Sorption. Publicada el 02/02/2011. Autores: G Fu, H He, Z Chai, H Chen, J Kong, Y Wang, Y Jiang Resumen: Surface molecular imprinting, in particular over nanosized support materials, is very suitable for a template of bulky structure like protein. Inspired by the surface template immobilization method reported previously, we herein demonstrate an alternative strategy for enhancing specific recognition of core-shell protein-imprinted nanoparticles through prefunctionalizing the cores with noncovalent template sorption groups. For proof of this concept, silica nanoparticles chosen as the core materials were modified consecutively with 3-aminopropyltrimethoxysilane and maleic anhydride to introduce polymerizable double bonds and terminal carboxyl groups, hence capable of physically adsorbing the print protein. With lysozyme as a template, thin protein-imprinted shells were fabricated according to our newly... ver más...Enero-Febrero 2011 Página 25
  29. 29. Nanomedicina Bioengineering Single Crystal Growth. Publicada el 02/02/2011. Autores: CH Wu, A Park, D Joester Resumen: Biomineralization is a "bottom-up" synthesis process that results in the formation of inorganic/organic nanocomposites with unrivaled control over structure, superior mechanical properties, adaptive response, and the capability of self-repair. While de novo design of such highly optimized materials may still be out of reach, engineering of the biosynthetic machinery may offer an alternative route to design advanced materials. Herein, we present an approach using micro-contact-printed lectins for patterning sea urchin embryo primary mesenchyme cells (PMCs) in vitro. We demonstrate not only that PMCs cultured on these substrates show attachment to wheat germ agglutinin and concanavalin A patterns but, more importantly, that the deposition and elongation of calcite spicules occurs cooperatively by multiple cells and in alignment... ver más... Unfolding and translocation pathway of substrate protein controlled by structure in repetitive allosteric cycles of the ClpY ATPase. Publicada en Nanomedicine Research Publicaciones, 02/02/2011. Autores: A Kravats, M Jayasinghe, G Stan Resumen: Clp ATPases are ring-shaped AAA+ motors in the degradation pathway that perform critical actions of unfolding and translocating substrate proteins (SPs) through narrow pores to deliver them to peptidase components. These actions are effected by conserved diaphragm-forming loops found in the central channel of the Clp ATPase hexamer. Conformational changes, that take place in the course of repetitive ATP-driven cycles, result in mechanical forces applied by the central channel loops onto the SP. We use coarse-grained simulations to elucidate allostery- driven mechanisms of unfolding and translocation of a tagged four-helix bundle protein by the ClpY ATPase. Unfolding is initiated at the tagged C-terminal region via an obligatory intermediate. The resulting nonnative conformation is competent for translocation, which proceeds... ver más...Enero-Febrero 2011 Página 26
  30. 30. Nanomedicina Modulation of biological processes in the nucleus by delivery of DNA oligonucleotides conjugated with gold nanoparticles Publicada el 02/02/2011. Autores: Kim, Dong-Wook. Kim, Jae-Hong. Park, Mira. Yeom, Ji-Hyun. Go, Hayoung. Kim, Sudeok. Han, Min Su. Bae, Jeehyeon Resumen: The development of a method that can efficiently deliver nucleic acids into the nucleus of living systems remains one of the key challenges for experimental and therapeutic use of nonbiological gene delivery agents. In the current study, we demonstrate a functionalized gold nanoparticle (AuNP) that can serve as a universal carrier for the delivery of DNA oligonucleotides (oligos) into the nucleus. We designed various types of DNA oligos to redirect alternative splicing of pre-mRNAs, such as MCL-1 and BCL-6, and to sequester transcriptional factors, including estrogen receptor and p53. We successfully delivered the oligos into the nucleus, resulting in the targeted effects. In addition, injection of the antisense DNAs into a xenograft... ver más... Multifunctional gadolinium-based dendritic macromolecules as liver targeting imaging probes Publicada el 02/02/2011. Autores: Kui Luoa, Gang Liua, Bin Hea, Yao Wua, Qingyong Gongb, Bin Songb, Hua Aia y Zhongwei Gu Resumen: In this paper, a novel series of Gd-based multifunctional peptide dendritic probes (generation 2, 3, and 4) possessing highly controlled structures and single molecular weight were designed and prepared as liver MRI probes. These macromolecular Gd-ligand agents exhibited up to 3-fold increase in T1relaxivity comparing to Gd-DTPA complexes. No obvious in vitro cytotoxicity was observed from the measured concentrations. These dendritic probes were further functionalized with multiple galactosyl moieties and led to much higher cell uptake in vitro as demonstrated in T1-weighted scans. During in vivo animal studies, the probes provided better signal intensity (SI) enhancement in mouse liver, especially at 60 min post-injection, with the most efficient enhancement from... ver más...Enero-Febrero 2011 Página 27
  31. 31. Nanomedicina Synthesis, characterization and cytotoxicity studies of chitosan-coated tea polyphenols nanoparticles Publicada el 02/02/2011. Autores: Liang J, Li F, Fang Y, Yang W, An X, Zhao L, Xin Z, Cao L, Hu Q Resumen: Chitosan nanoparticles (CS-NPs) were prepared by ionic gelation method using carboxymethyl chitosan and chitosan hydrochloride as carriers of tea polyphenols. The characteristics of chitosan-coated tea polyphenols nanoparticles (CS-TP NPs) were determined by using transmission electron microscopy (TEM) and FT-IR spectroscopy. It was found that the synthesized CS-TP NPs were non-spherical in shape with an average size of 407 ± 50 nm. Meanwhile, the drug content and encapsulation rate of the nanoparticles was 816% and 4483%, respectively. These CS-TP NPs also demonstrated sustained release of tea polyphenols in PBS. The antitumor of CS-TP NPs towards HepG2 cancer cells was investigated. The result showed that CS-TP NPs retained significant antitumor activities. ver más... In situ green synthesis of biocompatible ginseng capped gold nanoparticles with remarkable stability Publicada en Virtual Journal of Nanotechnology Environment, Health and Safety, 02/01/2011. Autores: Leonard K, Ahmmad B, Okamura H, Kurawaki J Resumen: This paper reports a one-step green synthesis of gold nanoparticles (G-AuNps), using naturally occurring Korean red ginseng root (Panax ginseng C.A. Meyer) and investigates their in vitro stability in various buffers as well as determining toxicity through detailed cytotoxicity assays using WST-8 counting kit, performed on normal cervical cells lines. ver más... Enhancement of cell recognition in vitro by dual-ligand cancer targeting gold nanoparticles Publicada en Scirus - Puclicaciones científicas sobre Nanomedicina - 2, 02/01/2011. Autores: Li, Xi. Zhou, Hongyu. Yang, Lei. Du, Guoqing. Pai-Panandiker, Atmaram S. Huang, Xuefei. Yan, Bing Resumen: A dual-ligand gold nanoparticle (DLGNP) was designed and synthesized to explore the therapeutic benefits of multivalent interactions between gold nanoparticles (GNPs) and cancer cells. DLGNP was tested on human epidermal cancer cells (KB), which had high expression of folate receptor. The cellular uptake of DLGNP was increased by 3.9 and 12.7 folds compared with GNP-folate or GNP-glucose. The enhanced cell recognition was due to multivalent interactions between both ligands on GNPs and cancer cells as shown by the ligand competition experiments. Furthermore, the multivalent interactions increased contrast between cells with high and low expression of folate receptors. The enhanced cell recognition enabled DLGNP to kill KB cells under X-ray irradiation at...Enero-Febrero 2011 Página 28
  32. 32. Nanomedicina ver más... Hemocompatible pullulan-polyethyleneimine conjugates for liver cell gene delivery: In vitro evaluation of cellular uptake, intracellular trafficking and transfection efficiency Publicada el 02/01/2011. Autores:Rekha MR, Sharma CP Resumen: In this study, polyethyleneimine (PEI; 25 kDa)-conjugated pullulans (PPE1, PPE2 and PPE3) were developed and investigated for possible use in gene delivery applications. The study included an investigation of the cellular uptake and localization of plasmid, as well as transgene expression, following in vitro transfection of HepG2 cells. ver más... Proteins of the Innate Immune System Crystallize on Carbon Nanotubes but Are Not Activated Publicada el 02/01/2011. Autores: Ling WL, Biro A, Bally I, Tacnet P, Deniaud A, Doris E, Frachet P, Schoehn G, Pebay-Peyroula E, Arlaud GJ Resumen: This study investigates the adsorption mechanisms of macromolecules on carbon nanotubes and the possibility of using carbon nanotubes for structural studies of macromolecules by observing the organized binding of C1 components C1q and C1s-C1r-C1r-C1s on carbon nanotubes. ver más...Enero-Febrero 2011 Página 29
  33. 33. Nanomedicina Liposomal architecture boosts biocompatibility of nanohybrid cerasomes Publicada el 02/01/2011. Autores: Ma Y, Dai Z, Gao Y, Cao Z, Xha Z, Yue X, Kikuchi JI Resumen: In this study, the authors report the cellular uptake of cerasomes and their biological effects toward human umbilical vein endothelial cells (HUVECs) compared with silica nanoparticles. ver más... Nanosilver induces minimal lung toxicity or inflammation in a subacute murine inhalation model Publicada el 02/01/2011. Autores: Stebounova LV, Adamcakova-Dodd A, Kim JS, Park H, OShaughnessy PT, Grassian VH, Thorne PS Resumen: The objective of this study was to determine whether very small commercially available nanosilver induces pulmonary toxicity in mice following inhalation exposure. ver más... A living cell quartz crystal microbalance biosensor for continuous monitoring of cytotoxic responses of macrophages to single-walled carbon nanotubes Publicada el 02/01/2011. Autores: Wang G, Dewilde AH, Zhang J, Pal A, Vashist M, Bello D, Marx KA, Braunhut SJ, Therrien JM Resumen: In this study, the authors have developed a device to detect and monitor in real time responses of living cells to engineered nanomaterials. The device, a living cell quartz crystal microbalance biosensor (QCMB), uses macrophages adherent to a quartz crystal. ver más...Enero-Febrero 2011 Página 30
  34. 34. Nanomedicina Inflammatory and cytotoxic responses of an alveolar- capillary coculture model to silica nanoparticles: comparison with conventional monocultures Publicada el 02/01/2011. Autores: Kasper J, Hermanns MI, Bantz C, Maskos M, Stauber R, Pohl C, Unger RE, Kirkpatrick CJ Resumen: In this study, the authors examined the inflammatory and cytotoxic responses of monodisperse amorphous silica nanoparticles (aSNPs) of 30 nm in size on an in vitro coculture model mimicking the alveolar-capillary barrier and compared these to conventional monocultures. ver más... Carbosilane dendrimers NN8 and NN16 form a stable complex with siGAG1 Publicada el 02/01/2011. Autores: Dzmitry Shcharbina, Elzbieta Pedziwiatrb, Olga Nowackab, Mayank Kumarb, Marian Zaborskic, Paula Ortegad, F. Javier de la Matad, Rafael Gómezd, Ma Angeles Muñoz-Fernandeze y Maria Bryszewskab Resumen: A new mechanism of gene expression inhibition has been discovered as RNA interference, in which the ability of double-stranded RNA to stimulate specific degradation of an mRNA target with a complementary sequence to one of the double-stranded RNA strands. Water-soluble carbosilane dendrimers containing ammonium or amine groups at their periphery are biocompatible molecules that may be good candidates as non-viral carriers of small interfering RNA. In studying the formation of complex between anti-HIV siRNA siGAG1 and carbosilane dendrimers NN8 and NN16 by circular dichroism, fluorescence, and zeta-potential, the size of nanoparticles formed has been estimated by... ver más... REPORTES Nanomedicina en España 06-10 Publicada el 02/03/2011. Documento que recoge las actividades de la Plataforma Española de Nanomedicina y de sus miembros desde la publicación de Visión de la Nanomedicina en España. ver más...Enero-Febrero 2011 Página 31
  35. 35. Nanomedicina Podcast: The Implications for Health, Safety and the Environment of the Nanotech Revolution Publicada el 02/03/2011. This podcast examines the issues associated with the nanotechnology revolution, specifically the effects on health, safety and the environment. ver más... Action Plan Nanotechnology 2015 Publicada el 02/03/2011. This action plan includes the German federal government action plan for nanotechnology in the period 2010-2015. The strategic aims include contributing to growth and innovation in Germany, safe and sustainable development of nanotechnology, using the potential of nanotechnology in education and research, and for solving global challenges. Applications include environmental protection, energy security, and contributing to a bioeconomy; healthcare, agrifood, environmentally friendly and energy saving mobility. The action plan includes also public dialogue and research in Environmental, Health and Safety aspects and Ethical, Legal and Social aspects. ver más... HTSM vision document: High Tech Systems and Material Publicada en Nanoforum.org - Reports, 02/02/2011. The focus of the vision document is on applications of nanoelectronics in health, mobility and sustainability. ver más...Enero-Febrero 2011 Página 32
  36. 36. Nanomedicina 2010 Nanotechnology Research Review Publicada en Market Research Nano-Medicine 2, 02/01/2011. This Nanotechnology Research Review provides a sampling of the type of quantitative market information, analysis and guidance that has been aiding business decision making since BCC was founded in 1971. It includes highlights from the following reports published in 2010: * Nanotechnology In Medical Applications: The Global Market * Nanocomposites, Nanoparticles, Nanoclays, And Nanotubes * Carbon Nanotubes: Technologies And Global Markets * Nanotechnology: A Realistic Market Assessment * Nanofibers: Technologies And Developing Markets * Nanotechnology In Paper Manufacturing: Global Markets ver más... Nanotechnology Market Forecast to 2013 Publicada en Market Research NanoMedicine, 02/01/2011. Nanotechnology Market Forecast to 2013 is a comprehensive research report that contains quality research, in-depth analysis, and authentic statistics of the global nanotechnology market. It studies emerging market trends, recent developments and their impact on the market along with an in depth analysis of nanotechnology patents. The report will help clients analyze leading-edge opportunities, prospective customer base, key players, expected future outlook, and all other factors critical to the success of a new entrant in the global nanotechnology market. ver más... Nanotechnologies in the 21st century Publicada en Nanoforum.org - Reports, 02/01/2011. Between April 2009 and September 2010, four reports have been published: 1) Challenges and opportunities to green nanotechnologies 2) Nanomaterials - health and environmental concerns 3) A critical review of governance issues in Europe and elsewhere 4) Shaping innovation: Policy approaches on innovation governance ver más...Enero-Febrero 2011 Página 33
  37. 37. Nanomedicina Nanotechnology Research Directions for Societal Needs in 2020. Retrospective and Outlook Publicada el 02/01/2011. This report outlines the foundational knowledge and infrastructure development achieved by nanotechnology in the last decade and explores the potentials of the U.S. and global nanotechnology enterprise to 2020 and beyond. It aims to redefine the R&D goals for nanoscale science and engineering integration, and to establish nanotechnology as a general-purpose technology in the next decade. The vision for the future of nanotechnology presented here draws on scientific insights from U.S. experts in the field, examinations of lessons learned, and international perspectives shared by participants from 35 countries in 5 international brainstorming meetings hosted or co-hosted by the principal authors of this report ver más... NORMATIVAS AENOR - Normativas de Nanotecnología Publicada en AENOR - Normativas de Nanotecnología, 02/03/2011. ISO 10808:2010: Caracterización de nanopartículas en cámaras de exposición por inhalación para ensayos de toxicidad por inhalación. Norma ratificada por AENOR en febrero de 2011. Normalización en el campo de las nanotecnologías que incluya alguno o ambos de los puntos siguientes: 1) Comprensión y control de la materia y los procesos en la nanoescala.. 2) Utilización de las propiedades de materiales en nanoescala que se diferencian de las propiedades de átomos, moléculas y materias individuales. ver más...Enero-Febrero 2011 Página 34

×